Regorafenib 40mg
The international pharmaceutical market requires dependable sourcing channels, accurate product documentation, and careful coordination between exporters, manufacturers, and authorized importers. For pharmaceutical distributors, wholesalers, hospital procurement teams, and licensed medicine importers, these considerations are especially important when sourcing oncology medicines such as regorafenib 40 mg.
Regorafenib is an oral targeted therapy belonging to the kinase inhibitor class. It is used for certain cancers under specialist medical supervision, including specific cases of colorectal cancer, gastrointestinal stromal tumours (GIST), and hepatocellular carcinoma, depending on the applicable product labeling and approved indication.
India is an established participant in the global pharmaceutical supply chain. International buyers may evaluate Indian pharmaceutical exporters when exploring potential sourcing options for oncology products. However, successful procurement requires more than a competitive quotation. Buyers should verify the actual manufacturer, product specifications, quality documents, destination-market requirements, and proposed shipping arrangements.
Dolphin Pharmaceuticals is an India-based pharmaceutical business that international buyers can contact to enquire about pharmaceutical sourcing requirements. Buyers interested in regorafenib 40 mg should confirm current availability, manufacturer details, documentation, and export eligibility directly with the company before placing an order.
This guide explains the key considerations for evaluating a potential Regorafenib 40 mg exporter from India.
Key Highlights
- Regorafenib 40 mg is an oral oncology medicine supplied as tablets in relevant product presentations.
- Buyers should confirm the exact product, strength, dosage form, pack size, and actual manufacturer.
- Product and batch documentation should match the medicine being offered.
- Export and import requirements depend on Indian regulations and the destination country's rules.
- Storage, packaging, shelf life, and shipping arrangements should be confirmed before dispatch.
- Dolphin Pharmaceuticals can be contacted to enquire about potential supply arrangements, subject to product availability and regulatory eligibility.
Regorafenib 40 mg: Product Overview
Regorafenib is a kinase inhibitor that acts on certain proteins involved in cancer-cell growth and tumour blood-vessel formation. It is used for particular oncology indications and is not suitable for every cancer type or patient. Treatment decisions must be made by qualified healthcare professionals.
Product Details
- Generic name: Regorafenib
- Strength: 40 mg
- Dosage form: Film-coated tablet in established product presentations; confirm the exact formulation offered.
- Therapeutic category: Oncology medicine / kinase inhibitor
- Route of administration: Oral, according to the applicable product labeling
- Potential procurement audience: Authorized pharmaceutical importers, distributors, wholesalers, and eligible healthcare procurement organizations
- Product availability: Must be confirmed with the proposed supplier
- Export eligibility: Depends on the product, manufacturer, destination market, and applicable regulatory requirements
Buyers should verify all details against the official product documentation for the medicine being offered. Different brands or manufacturers may have different packaging and market-specific authorization details.
What Is Regorafenib Used For?
Regorafenib is used in specific treatment settings involving certain cancers. Approved indications and treatment requirements can vary by jurisdiction and product labeling.
1. Colorectal Cancer
Regorafenib may be used for certain adults with metastatic colorectal cancer following specified previous treatments, depending on the applicable approved labeling.
2. Gastrointestinal Stromal Tumours
Regorafenib may be indicated for certain patients with locally advanced, unresectable, or metastatic gastrointestinal stromal tumours after previous treatment, as specified in the relevant product information.
3. Hepatocellular Carcinoma
Regorafenib may be used for certain patients with hepatocellular carcinoma who have previously received sorafenib, according to applicable product labeling.
The exact indication, eligibility criteria, and treatment sequence must be confirmed by a qualified healthcare professional using the product information approved in the relevant country.
This information is included to help pharmaceutical buyers understand the product category. It is not a treatment recommendation, and it does not imply that every regorafenib product is authorized for all of these indications in every market.
Why Consider Pharmaceutical Sourcing from India?
India has an established pharmaceutical manufacturing and export sector, and international buyers may evaluate Indian suppliers when seeking potential sources of generic and specialty medicines.
However, supplier selection should be based on verifiable product and business information rather than country of origin alone.
1. Access to Pharmaceutical Supply Networks
Indian pharmaceutical businesses operate across multiple therapeutic categories. Depending on their portfolios and sourcing arrangements, some may be able to respond to enquiries for oncology medicines.
When requesting a quotation, buyers should provide the exact generic name, strength, dosage form, required quantity, and destination country.
2. Opportunity to Compare Commercial Terms
Buyers often compare suppliers to understand the overall cost and feasibility of a procurement arrangement.
A useful comparison should consider:
- Product specifications and manufacturer
- Pack size and order quantity
- Remaining shelf life
- Documentation availability
- Shipping and insurance costs
- Payment terms
- Expected lead time
- Regulatory and import responsibilities
The lowest quoted price alone is not sufficient evidence of product quality, supplier reliability, or regulatory eligibility.
3. International Procurement Coordination
Cross-border pharmaceutical supply can involve manufacturers, exporters, freight providers, customs agents, and authorized importers.
Before confirming an order, buyers should clarify which party is responsible for providing product documents, preparing export paperwork, arranging transport, and coordinating with the importer.
Written confirmation of responsibilities can help reduce misunderstandings during the procurement process.
Dolphin Pharmaceuticals: International Pharmaceutical Supply Enquiries
Dolphin Pharmaceuticals is an India-based pharmaceutical business that international buyers can contact to discuss potential product sourcing requirements.
For a regorafenib 40 mg enquiry, buyers should request confirmation of whether the exact product can be supplied for their destination market.
Before proceeding, ask for information covering:
- Product availability and brand, if applicable
- Generic name and strength
- Dosage form and pack configuration
- Actual manufacturer and manufacturing location
- Relevant product specifications
- Available quality and batch documentation
- Remaining shelf life at dispatch
- Storage and transportation requirements
- Export eligibility for the destination country
- Quotation, minimum order quantity, and delivery terms
A supplier enquiry does not itself confirm that a product is in stock, approved for export, or authorized for sale in a particular country. These points should be verified before the order is finalized.
How to Evaluate a Regorafenib 40 mg Exporter
Selecting a suitable pharmaceutical exporter requires a structured review of supplier credentials, product information, quality documentation, and transaction requirements.
1. Verify the Supplier's Role
Determine whether the company manufactures the product, distributes it, or exports a medicine made by another manufacturer.
The actual manufacturer should be clearly identified. Buyers should not assume that the business handling the export transaction also manufactures the medicine.
Where applicable, verify the supplier's business credentials and authorizations relevant to its role in the pharmaceutical supply chain.
2. Confirm the Exact Product
Before accepting a quotation, confirm the following details:
- Generic name: regorafenib
- Strength: 40 mg
- Dosage form
- Brand name, if applicable
- Pack size and packaging configuration
- Actual manufacturer
- Country of manufacture
- Product registration or authorization details
The quotation, product labeling, and supporting documentation should be consistent. If any details differ, request clarification before proceeding.
3. Review Quality Documentation
Request documents appropriate to the product, manufacturer, destination market, and transaction.
Depending on the applicable requirements, these may include:
- Product specifications
- Manufacturer information
- Batch-specific certificate of analysis, where applicable
- Batch number and expiry information
- Relevant manufacturing or quality certifications
- Product registration or marketing authorization details
- Additional documents required by the importing authority
Documentation should correspond to the exact product being offered. Buyers should also establish how document authenticity can be checked when necessary.
4. Check Remaining Shelf Life
Remaining shelf life is an important factor in international pharmaceutical procurement. Buyers should confirm the expected expiry period at dispatch and ensure it meets the requirements of the importer and destination market.
The review should account for expected shipping time, customs clearance, receipt checks, and local distribution.
5. Confirm Supply and Delivery Terms
Obtain written details covering the proposed quantity, packaging, price, payment terms, expected lead time, shipping method, and responsibilities for transport and import clearance.
For recurring requirements, buyers may also discuss future supply arrangements. Any expected schedule should remain subject to product availability, manufacturing capacity, and regulatory requirements.
Documentation for International Regorafenib Procurement
The documents required for exporting and importing regorafenib 40 mg depend on the product, transaction, and destination country.
Product Documentation
Product documentation can include the generic name, strength, dosage form, manufacturer details, specifications, labeling, and other information needed to identify the medicine.
Quality Documentation
Depending on applicable requirements, quality records may include a certificate of analysis, batch-related information, and relevant manufacturing or quality-system documentation.
Commercial Documentation
Common commercial documents may include:
- Quotation
- Purchase order
- Commercial invoice
- Packing list
- Agreed shipping and payment terms
Regulatory Documentation
The destination market may require product registration, an import permit, importer authorization, or additional certificates. Requirements should be confirmed with the competent authority before shipment.
Shipping Documentation
Shipping documents depend on the transport method, customs process, and product-specific requirements. Exporters and importers should agree in advance on who will prepare and provide each document.
This is a general procurement guide rather than a universal checklist. Buyers should obtain a destination-specific document list before authorizing shipment.
Regulatory Considerations for Exporting Medicines from India
Pharmaceutical exports must comply with applicable Indian requirements and the rules of the destination market. India's regulatory framework includes requirements relating to drug manufacturing, labeling, and export procedures.
Before arranging a shipment, the relevant parties should confirm:
- Whether the manufacturer and product meet applicable Indian requirements
- Whether any additional permission or no-objection certificate is needed for the specific product
- Whether the product is authorized for import and sale in the destination country
- Whether the importing organization has the required authorization
- Which labeling and packaging rules apply
- Which regulatory and customs documents must accompany the shipment
Requirements may differ depending on the product's approval status and the destination country's laws. Buyers should obtain current guidance from the relevant authorities or qualified regulatory professionals.
Important: Availability in India does not automatically establish eligibility for export or import. Confirm the legal status of the exact product and proposed transaction before placing an order.
Storage, Packaging, and Transportation
Regorafenib products must be stored and transported according to the specific manufacturer's approved instructions and the requirements applicable to the product.
Buyers should request the relevant storage information before agreeing to shipping arrangements.
Procurement teams should review:
- Manufacturer-specified storage conditions
- Packaging integrity requirements
- Protection from unsuitable environmental conditions
- Expected transit time
- Customs-clearance arrangements
- Procedures for checking the shipment upon receipt
Storage instructions can vary by product and presentation. Buyers should follow the official instructions supplied for the exact medicine rather than assuming that all brands have identical requirements.
Upon receipt, the importing organization should follow its quality procedures to check the packaging, product identity, batch details, expiry information, and any shipment discrepancies.
Commercial Considerations for Pharmaceutical Buyers
A clear procurement enquiry can help the supplier assess the request more efficiently.
When requesting a quotation for regorafenib 40 mg, include:
- Product: Regorafenib 40 mg
- Dosage form: Specify the required presentation
- Quantity: State the requested quantity and packaging
- Destination: Identify the importing country and delivery location
- Manufacturer preference: Include any approved or preferred manufacturer, if applicable
- Documentation: List required product, quality, and regulatory documents
- Regulatory status: Provide any relevant registration or import information already available
- Delivery requirements: Specify expected shipping terms and product-handling needs
Ask the supplier to confirm the quoted product's identity, manufacturer, availability, remaining shelf life, documentation, and export eligibility before accepting the offer.
For wholesale and institutional buyers, written confirmation of these details supports a more transparent procurement process.
Common Mistakes to Avoid When Sourcing Regorafenib 40 mg
Choosing Only by Price
A low quotation does not establish product quality or regulatory eligibility. Compare the full offer, including documentation, shelf life, shipping, and import responsibilities.
Confusing the Exporter with the Manufacturer
The business exporting a medicine may not manufacture it. Confirm the actual manufacturer and check that the supporting documents match the product.
Assuming Approval Is Universal
A product authorized in one market may not be authorized in another. Verify the applicable requirements for the destination country before shipment.
Overlooking Shelf Life and Transit Time
International shipping and customs clearance take time. Confirm the remaining shelf life at dispatch and ensure the product will meet the importer's requirements upon receipt.
Leaving Documentation Until the Last Minute
Do not wait until the shipment is ready to leave before checking the documents required by the importer and authorities. Agree on the document requirements before confirming the order.
Frequently Asked Questions
1. What is regorafenib 40 mg?
Regorafenib 40 mg is a tablet strength of regorafenib, an oral kinase inhibitor used for specific oncology indications under medical supervision. The approved uses depend on the product labeling and the destination market.
2. How can I find a regorafenib 40 mg exporter from India?
Identify potential pharmaceutical exporters and request product-specific information. Verify the actual manufacturer, product details, quality documentation, supplier credentials, and export eligibility for the intended destination.
3. Can Dolphin Pharmaceuticals supply regorafenib 40 mg?
Interested buyers can contact Dolphin Pharmaceuticals to enquire about the specific product. Current availability, manufacturer details, documentation, pricing, and destination-market eligibility must be confirmed directly with the company.
4. What documents should buyers request?
Depending on the product and destination, buyers may need product specifications, manufacturer information, applicable batch quality documents, expiry details, commercial documents, and relevant regulatory approvals or permits.
5. Can regorafenib 40 mg be exported to every country?
No universal export or import eligibility should be assumed. Requirements depend on the destination country's regulatory framework, the specific product, manufacturer, and proposed transaction.
6. What should buyers check before placing an order?
Confirm product identity, strength, dosage form, manufacturer, availability, documentation, remaining shelf life, storage requirements, commercial terms, and destination-market authorization.
7. Does a pharmaceutical exporter always manufacture the medicine?
No. An exporter may manufacture the product, distribute it, or source it from another manufacturer. Buyers should confirm the actual manufacturer for each product.
Conclusion
Sourcing regorafenib 40 mg internationally requires careful evaluation of product specifications, supplier credentials, manufacturer information, quality documentation, regulatory status, and shipping arrangements.
India offers an established pharmaceutical export sector, and international buyers may evaluate Indian suppliers according to their specific product requirements. Dolphin Pharmaceuticals can be contacted to enquire about regorafenib 40 mg and potential supply arrangements. Availability, manufacturer details, supporting documents, and destination-country export eligibility should be confirmed directly before an order is placed.
For pharmaceutical importers, wholesalers, distributors, and healthcare procurement organizations, a transparent and well-documented purchasing process is essential. By verifying the product and regulatory requirements in advance, buyers can make informed sourcing decisions and coordinate international pharmaceutical procurement responsibly.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/